Matthew Keller
Concepts (499)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 44 | 2025 | 1378 | 4.710 |
Why?
| | Polymorphism, Single Nucleotide | 55 | 2026 | 2146 | 4.580 |
Why?
| | Biological Specimen Banks | 7 | 2025 | 105 | 3.920 |
Why?
| | Models, Genetic | 23 | 2025 | 531 | 3.040 |
Why?
| | Multifactorial Inheritance | 17 | 2025 | 190 | 3.020 |
Why?
| | Schizophrenia | 16 | 2022 | 444 | 2.890 |
Why?
| | Genetic Predisposition to Disease | 35 | 2025 | 2355 | 2.760 |
Why?
| | Gene-Environment Interaction | 9 | 2021 | 178 | 1.860 |
Why?
| | Dermatology | 5 | 2025 | 129 | 1.820 |
Why?
| | Homozygote | 11 | 2023 | 200 | 1.740 |
Why?
| | Genome, Human | 13 | 2021 | 420 | 1.670 |
Why?
| | Genetics, Population | 5 | 2022 | 217 | 1.620 |
Why?
| | Phenotype | 32 | 2025 | 3157 | 1.600 |
Why?
| | Genetic Variation | 19 | 2022 | 988 | 1.500 |
Why?
| | Paternal Inheritance | 2 | 2021 | 3 | 1.330 |
Why?
| | Maternal Inheritance | 2 | 2021 | 15 | 1.330 |
Why?
| | Statistics as Topic | 3 | 2021 | 284 | 1.320 |
Why?
| | Consanguinity | 4 | 2018 | 49 | 1.180 |
Why?
| | Genomics | 10 | 2026 | 834 | 1.170 |
Why?
| | United Kingdom | 9 | 2025 | 339 | 1.110 |
Why?
| | Twins | 5 | 2021 | 152 | 1.100 |
Why?
| | Quantitative Trait, Heritable | 8 | 2025 | 115 | 1.090 |
Why?
| | Mental Disorders | 12 | 2022 | 1157 | 1.070 |
Why?
| | Sequence Analysis, DNA | 3 | 2017 | 831 | 1.070 |
Why?
| | Humans | 150 | 2026 | 145491 | 1.060 |
Why?
| | Family | 7 | 2024 | 687 | 1.060 |
Why?
| | Twins, Dizygotic | 6 | 2013 | 109 | 1.050 |
Why?
| | Linkage Disequilibrium | 7 | 2026 | 249 | 1.020 |
Why?
| | Family Characteristics | 2 | 2025 | 198 | 1.010 |
Why?
| | Marriage | 3 | 2025 | 122 | 0.980 |
Why?
| | Genome | 3 | 2018 | 305 | 0.980 |
Why?
| | Twins, Monozygotic | 5 | 2013 | 134 | 0.950 |
Why?
| | Academic Success | 2 | 2023 | 30 | 0.950 |
Why?
| | Cognition | 15 | 2022 | 1268 | 0.930 |
Why?
| | Chromosomes | 1 | 2026 | 108 | 0.920 |
Why?
| | Reproduction | 4 | 2022 | 207 | 0.910 |
Why?
| | Smoking | 7 | 2025 | 1468 | 0.900 |
Why?
| | Family Health | 2 | 2024 | 191 | 0.870 |
Why?
| | Software | 3 | 2017 | 698 | 0.870 |
Why?
| | Haplotypes | 5 | 2026 | 498 | 0.870 |
Why?
| | Infant, Low Birth Weight | 1 | 2025 | 156 | 0.850 |
Why?
| | Environment | 5 | 2017 | 307 | 0.840 |
Why?
| | Spouses | 1 | 2025 | 108 | 0.820 |
Why?
| | Sexual Partners | 1 | 2025 | 193 | 0.800 |
Why?
| | Communication Barriers | 2 | 2016 | 130 | 0.800 |
Why?
| | Informed Consent | 2 | 2016 | 197 | 0.790 |
Why?
| | Genotype | 13 | 2021 | 1853 | 0.790 |
Why?
| | Genetics, Behavioral | 2 | 2020 | 17 | 0.780 |
Why?
| | Depression | 4 | 2022 | 1573 | 0.780 |
Why?
| | Body Height | 6 | 2025 | 200 | 0.750 |
Why?
| | Algorithms | 4 | 2026 | 1855 | 0.740 |
Why?
| | Biological Evolution | 4 | 2018 | 488 | 0.740 |
Why?
| | Mentors | 2 | 2025 | 218 | 0.720 |
Why?
| | Intelligence | 6 | 2025 | 112 | 0.720 |
Why?
| | Female | 79 | 2026 | 78763 | 0.700 |
Why?
| | Tobacco Use Disorder | 3 | 2025 | 218 | 0.700 |
Why?
| | Pedigree | 5 | 2024 | 515 | 0.660 |
Why?
| | Educational Status | 8 | 2024 | 465 | 0.650 |
Why?
| | Computer Simulation | 7 | 2022 | 1026 | 0.650 |
Why?
| | Male | 67 | 2026 | 72817 | 0.650 |
Why?
| | Inbreeding Depression | 2 | 2021 | 3 | 0.640 |
Why?
| | Research Design | 6 | 2018 | 1134 | 0.610 |
Why?
| | Adult | 51 | 2026 | 40707 | 0.600 |
Why?
| | Twin Studies as Topic | 3 | 2018 | 14 | 0.600 |
Why?
| | Alleles | 10 | 2024 | 893 | 0.600 |
Why?
| | Wearable Electronic Devices | 3 | 2025 | 66 | 0.590 |
Why?
| | Bias | 5 | 2022 | 198 | 0.590 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 651 | 0.570 |
Why?
| | Cervical Length Measurement | 1 | 2018 | 5 | 0.560 |
Why?
| | Alcoholism | 6 | 2025 | 821 | 0.560 |
Why?
| | Hyperhidrosis | 1 | 2018 | 6 | 0.550 |
Why?
| | Fees and Charges | 1 | 2018 | 11 | 0.550 |
Why?
| | Psychological Trauma | 1 | 2019 | 57 | 0.550 |
Why?
| | Botulinum Toxins | 1 | 2018 | 47 | 0.520 |
Why?
| | Tympanoplasty | 1 | 2017 | 9 | 0.520 |
Why?
| | Tympanic Membrane Perforation | 1 | 2017 | 18 | 0.520 |
Why?
| | Auditory Threshold | 1 | 2017 | 51 | 0.510 |
Why?
| | Socioeconomic Factors | 3 | 2019 | 1327 | 0.500 |
Why?
| | Beauty | 2 | 2013 | 19 | 0.500 |
Why?
| | Blast Injuries | 1 | 2017 | 62 | 0.500 |
Why?
| | Drug Eruptions | 1 | 2016 | 28 | 0.490 |
Why?
| | Third-Party Consent | 1 | 2016 | 21 | 0.490 |
Why?
| | Erlotinib Hydrochloride | 1 | 2016 | 72 | 0.490 |
Why?
| | Proxy | 1 | 2016 | 35 | 0.480 |
Why?
| | Psychotic Disorders | 2 | 2016 | 185 | 0.480 |
Why?
| | Skin Neoplasms | 2 | 2014 | 850 | 0.480 |
Why?
| | Adaptation, Physiological | 3 | 2018 | 570 | 0.470 |
Why?
| | Genetic Loci | 9 | 2022 | 260 | 0.460 |
Why?
| | Patient Acceptance of Health Care | 3 | 2021 | 884 | 0.460 |
Why?
| | Chromosome Mapping | 4 | 2026 | 509 | 0.460 |
Why?
| | Creativity | 1 | 2015 | 18 | 0.450 |
Why?
| | Internship and Residency | 2 | 2025 | 1265 | 0.440 |
Why?
| | Nootropic Agents | 3 | 2021 | 30 | 0.440 |
Why?
| | Physician-Patient Relations | 3 | 2016 | 590 | 0.430 |
Why?
| | Body Mass Index | 5 | 2024 | 2425 | 0.430 |
Why?
| | Likelihood Functions | 5 | 2022 | 140 | 0.420 |
Why?
| | Parkinson Disease | 3 | 2025 | 601 | 0.410 |
Why?
| | Quantitative Trait Loci | 4 | 2024 | 375 | 0.410 |
Why?
| | Genealogy and Heraldry | 1 | 2013 | 3 | 0.400 |
Why?
| | Nevus, Pigmented | 1 | 2014 | 35 | 0.400 |
Why?
| | Deglutition Disorders | 2 | 2025 | 154 | 0.390 |
Why?
| | Middle Aged | 34 | 2026 | 36176 | 0.390 |
Why?
| | Cocaine-Related Disorders | 1 | 2015 | 133 | 0.390 |
Why?
| | Genetic Pleiotropy | 1 | 2013 | 30 | 0.380 |
Why?
| | Depressive Disorder | 2 | 2007 | 387 | 0.380 |
Why?
| | Bipolar Disorder | 2 | 2015 | 278 | 0.380 |
Why?
| | Medication Therapy Management | 1 | 2013 | 72 | 0.380 |
Why?
| | Metabolic Networks and Pathways | 1 | 2014 | 187 | 0.370 |
Why?
| | Telemedicine | 1 | 2022 | 960 | 0.370 |
Why?
| | Fluorouracil | 1 | 2013 | 235 | 0.370 |
Why?
| | Affect | 2 | 2005 | 322 | 0.370 |
Why?
| | Dementia | 1 | 2016 | 325 | 0.360 |
Why?
| | Genes, Recessive | 1 | 2012 | 78 | 0.360 |
Why?
| | Marijuana Abuse | 1 | 2015 | 211 | 0.360 |
Why?
| | Inbreeding | 1 | 2011 | 20 | 0.350 |
Why?
| | Gene Frequency | 6 | 2022 | 483 | 0.340 |
Why?
| | Sex Characteristics | 2 | 2013 | 779 | 0.340 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 320 | 0.340 |
Why?
| | Young Adult | 20 | 2026 | 14192 | 0.330 |
Why?
| | Social Environment | 4 | 2019 | 253 | 0.320 |
Why?
| | Genetic Markers | 3 | 2020 | 334 | 0.320 |
Why?
| | Adaptation, Psychological | 3 | 2022 | 718 | 0.310 |
Why?
| | Risk Factors | 14 | 2025 | 10874 | 0.310 |
Why?
| | Substance-Related Disorders | 5 | 2025 | 1097 | 0.310 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2021 | 103 | 0.310 |
Why?
| | Live Birth | 2 | 2020 | 69 | 0.310 |
Why?
| | Bariatric Surgery | 2 | 2024 | 245 | 0.310 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2009 | 28 | 0.300 |
Why?
| | Uniparental Disomy | 1 | 2009 | 9 | 0.300 |
Why?
| | Aged | 18 | 2026 | 26125 | 0.300 |
Why?
| | Models, Statistical | 5 | 2018 | 679 | 0.300 |
Why?
| | Negative-Pressure Wound Therapy | 2 | 2020 | 29 | 0.300 |
Why?
| | Life Change Events | 2 | 2007 | 147 | 0.290 |
Why?
| | Fathers | 1 | 2009 | 52 | 0.290 |
Why?
| | Stillbirth | 2 | 2019 | 81 | 0.290 |
Why?
| | Personality | 2 | 2012 | 129 | 0.280 |
Why?
| | Models, Theoretical | 3 | 2021 | 579 | 0.280 |
Why?
| | Dysphonia | 2 | 2018 | 13 | 0.280 |
Why?
| | Retrospective Studies | 18 | 2026 | 17269 | 0.280 |
Why?
| | Psychiatry | 1 | 2011 | 196 | 0.280 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 4 | 2025 | 232 | 0.280 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 644 | 0.280 |
Why?
| | Laryngeal Diseases | 2 | 2018 | 31 | 0.270 |
Why?
| | Mendelian Randomization Analysis | 3 | 2024 | 54 | 0.270 |
Why?
| | Evolution, Molecular | 2 | 2017 | 518 | 0.270 |
Why?
| | Registries | 2 | 2015 | 2410 | 0.270 |
Why?
| | Adolescent | 27 | 2026 | 22485 | 0.270 |
Why?
| | Psoriasis | 2 | 2021 | 115 | 0.270 |
Why?
| | Genetic Association Studies | 4 | 2019 | 369 | 0.270 |
Why?
| | Inheritance Patterns | 4 | 2021 | 44 | 0.270 |
Why?
| | Parent-Child Relations | 2 | 2021 | 271 | 0.260 |
Why?
| | Inappropriate Prescribing | 2 | 2026 | 66 | 0.260 |
Why?
| | Myeloproliferative Disorders | 2 | 2019 | 21 | 0.260 |
Why?
| | Chromosomes, Human | 3 | 2018 | 41 | 0.260 |
Why?
| | Computational Biology | 1 | 2011 | 687 | 0.240 |
Why?
| | Pediatric Obesity | 2 | 2024 | 637 | 0.240 |
Why?
| | Facial Injuries | 1 | 2026 | 25 | 0.230 |
Why?
| | Reproducibility of Results | 4 | 2019 | 3424 | 0.230 |
Why?
| | Practice Patterns, Physicians' | 2 | 2021 | 1369 | 0.230 |
Why?
| | Pregnancy | 7 | 2025 | 7197 | 0.230 |
Why?
| | Selection, Genetic | 2 | 2012 | 258 | 0.230 |
Why?
| | Neurodevelopmental Disorders | 2 | 2019 | 226 | 0.220 |
Why?
| | Weather | 1 | 2005 | 43 | 0.220 |
Why?
| | Surveys and Questionnaires | 6 | 2025 | 6070 | 0.220 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 2207 | 0.220 |
Why?
| | Positive-Pressure Respiration | 1 | 2026 | 115 | 0.220 |
Why?
| | Biofeedback, Psychology | 1 | 2025 | 35 | 0.220 |
Why?
| | Noninvasive Ventilation | 1 | 2026 | 62 | 0.220 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2025 | 63 | 0.220 |
Why?
| | Executive Function | 2 | 2022 | 469 | 0.220 |
Why?
| | Needs Assessment | 2 | 2020 | 401 | 0.210 |
Why?
| | Recombination, Genetic | 2 | 2016 | 205 | 0.200 |
Why?
| | Apolipoproteins E | 1 | 2024 | 94 | 0.200 |
Why?
| | Alcohol Drinking | 2 | 2022 | 837 | 0.200 |
Why?
| | Pregnancy Complications | 2 | 2019 | 612 | 0.200 |
Why?
| | Cognition Disorders | 2 | 2019 | 541 | 0.190 |
Why?
| | Tobacco Products | 1 | 2024 | 84 | 0.190 |
Why?
| | Hidradenitis Suppurativa | 1 | 2022 | 11 | 0.190 |
Why?
| | Ureteral Calculi | 1 | 2022 | 15 | 0.190 |
Why?
| | Parents | 2 | 2022 | 1404 | 0.190 |
Why?
| | Population Health | 1 | 2023 | 44 | 0.180 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2022 | 44 | 0.180 |
Why?
| | Lithotripsy | 1 | 2022 | 53 | 0.180 |
Why?
| | Birth Weight | 1 | 2025 | 511 | 0.180 |
Why?
| | Face | 2 | 2013 | 177 | 0.180 |
Why?
| | Receptors, Nicotinic | 2 | 2025 | 328 | 0.180 |
Why?
| | Tobacco Use | 1 | 2022 | 62 | 0.180 |
Why?
| | Internationality | 1 | 2022 | 156 | 0.180 |
Why?
| | Fractures, Open | 1 | 2022 | 28 | 0.180 |
Why?
| | Faculty, Medical | 1 | 2025 | 301 | 0.180 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2022 | 427 | 0.180 |
Why?
| | Compartment Syndromes | 1 | 2022 | 36 | 0.170 |
Why?
| | Health Care Costs | 2 | 2022 | 427 | 0.170 |
Why?
| | Mutation, Missense | 2 | 2019 | 338 | 0.170 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 15 | 0.170 |
Why?
| | Respiratory Rate | 1 | 2021 | 23 | 0.170 |
Why?
| | Tibial Fractures | 1 | 2022 | 73 | 0.170 |
Why?
| | Wireless Technology | 1 | 2021 | 18 | 0.170 |
Why?
| | Gastric Bypass | 1 | 2022 | 126 | 0.170 |
Why?
| | Tremor | 2 | 2018 | 98 | 0.160 |
Why?
| | Genotyping Techniques | 2 | 2018 | 72 | 0.160 |
Why?
| | Respiratory Sounds | 1 | 2021 | 103 | 0.160 |
Why?
| | Pregnancy, Twin | 1 | 2020 | 19 | 0.160 |
Why?
| | Arthroplasty, Replacement | 1 | 2021 | 47 | 0.160 |
Why?
| | Cohort Studies | 7 | 2026 | 5992 | 0.160 |
Why?
| | Inpatients | 2 | 2022 | 550 | 0.160 |
Why?
| | Aged, 80 and over | 7 | 2026 | 8326 | 0.160 |
Why?
| | Artificial Intelligence | 1 | 2025 | 383 | 0.150 |
Why?
| | Hysterectomy | 1 | 2021 | 137 | 0.150 |
Why?
| | Analgesics, Opioid | 2 | 2026 | 1150 | 0.150 |
Why?
| | Mental Health | 2 | 2024 | 795 | 0.150 |
Why?
| | Hospitalization | 5 | 2021 | 2458 | 0.150 |
Why?
| | Behavior, Addictive | 1 | 2020 | 88 | 0.150 |
Why?
| | Medicaid | 2 | 2021 | 466 | 0.150 |
Why?
| | Maternal Health | 1 | 2019 | 50 | 0.150 |
Why?
| | Friends | 1 | 2019 | 57 | 0.150 |
Why?
| | History, 21st Century | 1 | 2020 | 220 | 0.150 |
Why?
| | Duffy Blood-Group System | 1 | 2019 | 5 | 0.150 |
Why?
| | Exotoxins | 1 | 2019 | 16 | 0.150 |
Why?
| | Florida | 4 | 2019 | 118 | 0.150 |
Why?
| | Siblings | 2 | 2013 | 195 | 0.150 |
Why?
| | Janus Kinase 2 | 1 | 2019 | 29 | 0.150 |
Why?
| | Orbital Cellulitis | 1 | 2019 | 17 | 0.150 |
Why?
| | Dermatitis, Atopic | 1 | 2022 | 323 | 0.150 |
Why?
| | Cone Opsins | 1 | 2018 | 2 | 0.150 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 36 | 0.140 |
Why?
| | Hemolysin Proteins | 1 | 2019 | 36 | 0.140 |
Why?
| | Laryngismus | 1 | 2018 | 10 | 0.140 |
Why?
| | History, 20th Century | 1 | 2020 | 327 | 0.140 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2018 | 20 | 0.140 |
Why?
| | Antimicrobial Stewardship | 1 | 2021 | 130 | 0.140 |
Why?
| | Obesity, Morbid | 1 | 2022 | 288 | 0.140 |
Why?
| | Bacterial Toxins | 1 | 2019 | 109 | 0.140 |
Why?
| | Urinary Tract Infections | 1 | 2021 | 210 | 0.140 |
Why?
| | Chronic Pain | 1 | 2023 | 291 | 0.140 |
Why?
| | Lasers | 1 | 2018 | 128 | 0.140 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2019 | 90 | 0.140 |
Why?
| | Recurrence | 2 | 2019 | 1142 | 0.140 |
Why?
| | Pregnancy Trimester, Second | 1 | 2018 | 83 | 0.140 |
Why?
| | Time-to-Treatment | 1 | 2020 | 250 | 0.130 |
Why?
| | Europe | 2 | 2022 | 421 | 0.130 |
Why?
| | Laparoscopy | 1 | 2022 | 481 | 0.130 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2945 | 0.130 |
Why?
| | Follow-Up Studies | 4 | 2025 | 5426 | 0.130 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2020 | 182 | 0.130 |
Why?
| | Opioid-Related Disorders | 1 | 2026 | 601 | 0.130 |
Why?
| | Audiometry, Pure-Tone | 1 | 2017 | 33 | 0.130 |
Why?
| | Neuromuscular Agents | 1 | 2018 | 46 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2022 | 389 | 0.130 |
Why?
| | Botulinum Toxins, Type A | 1 | 2018 | 59 | 0.130 |
Why?
| | Mouth | 1 | 2017 | 88 | 0.130 |
Why?
| | Synaptic Transmission | 1 | 2019 | 292 | 0.130 |
Why?
| | Event-Related Potentials, P300 | 1 | 2016 | 16 | 0.130 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 306 | 0.130 |
Why?
| | Databases, Factual | 4 | 2025 | 1500 | 0.130 |
Why?
| | Heart Rate | 1 | 2021 | 859 | 0.130 |
Why?
| | Endophenotypes | 1 | 2016 | 22 | 0.130 |
Why?
| | Neurocognitive Disorders | 1 | 2017 | 33 | 0.130 |
Why?
| | Education, Medical, Graduate | 1 | 2022 | 564 | 0.120 |
Why?
| | Case-Control Studies | 4 | 2017 | 3619 | 0.120 |
Why?
| | Hematologic Neoplasms | 1 | 2019 | 168 | 0.120 |
Why?
| | Parenting | 1 | 2020 | 319 | 0.120 |
Why?
| | Receptors, Cell Surface | 1 | 2019 | 372 | 0.120 |
Why?
| | Patient Discharge | 2 | 2022 | 992 | 0.120 |
Why?
| | Patient Readmission | 1 | 2022 | 769 | 0.120 |
Why?
| | Postpartum Period | 1 | 2019 | 373 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 623 | 0.120 |
Why?
| | United States | 8 | 2026 | 16115 | 0.120 |
Why?
| | Phylogeny | 1 | 2021 | 1028 | 0.120 |
Why?
| | Regression Analysis | 3 | 2021 | 1001 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 616 | 0.120 |
Why?
| | Retina | 1 | 2018 | 321 | 0.120 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 150 | 0.120 |
Why?
| | Referral and Consultation | 1 | 2022 | 862 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2019 | 441 | 0.120 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 184 | 0.120 |
Why?
| | Telephone | 1 | 2016 | 177 | 0.110 |
Why?
| | Pityriasis Rubra Pilaris | 1 | 2015 | 1 | 0.110 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2020 | 372 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2020 | 608 | 0.110 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2015 | 22 | 0.110 |
Why?
| | Guanylate Cyclase | 1 | 2015 | 38 | 0.110 |
Why?
| | Genetic Research | 1 | 2015 | 17 | 0.110 |
Why?
| | Curriculum | 1 | 2022 | 1068 | 0.110 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2015 | 130 | 0.110 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 2002 | 0.110 |
Why?
| | Staphylococcus aureus | 1 | 2019 | 455 | 0.110 |
Why?
| | Comprehension | 1 | 2016 | 184 | 0.110 |
Why?
| | Staphylococcal Infections | 1 | 2019 | 391 | 0.110 |
Why?
| | Adolescent Behavior | 1 | 2019 | 497 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2015 | 196 | 0.100 |
Why?
| | Comorbidity | 2 | 2019 | 1659 | 0.100 |
Why?
| | Masculinity | 1 | 2013 | 11 | 0.100 |
Why?
| | Asthma | 1 | 2026 | 1795 | 0.100 |
Why?
| | Antisocial Personality Disorder | 1 | 2015 | 121 | 0.100 |
Why?
| | Genetic Testing | 1 | 2017 | 480 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2024 | 1164 | 0.100 |
Why?
| | Genetic Fitness | 1 | 2014 | 59 | 0.100 |
Why?
| | Moral Obligations | 1 | 2013 | 15 | 0.100 |
Why?
| | Prescription Drug Diversion | 1 | 2013 | 13 | 0.100 |
Why?
| | Stress, Psychological | 1 | 2022 | 1153 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2025 | 6437 | 0.100 |
Why?
| | Biopsy, Needle | 1 | 2014 | 185 | 0.100 |
Why?
| | Impulsive Behavior | 1 | 2015 | 145 | 0.100 |
Why?
| | Administration, Topical | 1 | 2013 | 153 | 0.100 |
Why?
| | Liability, Legal | 1 | 2013 | 43 | 0.100 |
Why?
| | Interpersonal Relations | 2 | 2008 | 401 | 0.100 |
Why?
| | Africa | 1 | 2013 | 119 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2015 | 320 | 0.100 |
Why?
| | Biopsy | 1 | 2016 | 1081 | 0.100 |
Why?
| | Child | 10 | 2026 | 22680 | 0.100 |
Why?
| | Outpatients | 1 | 2016 | 447 | 0.090 |
Why?
| | Adolescent Development | 1 | 2013 | 72 | 0.090 |
Why?
| | Endothelial Cells | 1 | 2019 | 866 | 0.090 |
Why?
| | Anxiety Disorders | 1 | 2016 | 370 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 980 | 0.090 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2373 | 0.090 |
Why?
| | Hematopoietic Stem Cells | 1 | 2015 | 419 | 0.090 |
Why?
| | Bacterial Proteins | 1 | 2019 | 991 | 0.090 |
Why?
| | Choice Behavior | 1 | 2013 | 180 | 0.090 |
Why?
| | Treatment Outcome | 4 | 2022 | 11831 | 0.090 |
Why?
| | Parathyroid Glands | 1 | 2011 | 11 | 0.090 |
Why?
| | Monitoring, Physiologic | 2 | 2025 | 288 | 0.090 |
Why?
| | Homeostasis | 1 | 2015 | 639 | 0.090 |
Why?
| | Cell Cycle Proteins | 1 | 2015 | 631 | 0.090 |
Why?
| | NF-kappa B | 1 | 2015 | 660 | 0.080 |
Why?
| | Virginia | 2 | 2009 | 55 | 0.080 |
Why?
| | Life Style | 2 | 2021 | 483 | 0.080 |
Why?
| | Population Density | 1 | 2011 | 102 | 0.080 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2011 | 70 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 1 | 2011 | 159 | 0.080 |
Why?
| | Anthropometry | 2 | 2024 | 205 | 0.070 |
Why?
| | Microbiota | 1 | 2017 | 784 | 0.070 |
Why?
| | Military Personnel | 1 | 2017 | 737 | 0.070 |
Why?
| | Sexual Behavior | 1 | 2013 | 496 | 0.070 |
Why?
| | Decision Making | 1 | 2016 | 979 | 0.070 |
Why?
| | International Classification of Diseases | 2 | 2019 | 148 | 0.070 |
Why?
| | Child Development | 1 | 2013 | 484 | 0.070 |
Why?
| | Risk | 3 | 2019 | 917 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2950 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2016 | 891 | 0.070 |
Why?
| | Child, Preschool | 5 | 2026 | 11837 | 0.070 |
Why?
| | Prevalence | 1 | 2015 | 2855 | 0.070 |
Why?
| | Databases, Genetic | 1 | 2009 | 248 | 0.070 |
Why?
| | Thinking | 1 | 2008 | 66 | 0.060 |
Why?
| | Personality Inventory | 1 | 2007 | 134 | 0.060 |
Why?
| | Diseases in Twins | 1 | 2007 | 115 | 0.060 |
Why?
| | Health Status | 2 | 2024 | 836 | 0.060 |
Why?
| | Analysis of Variance | 3 | 2018 | 1304 | 0.060 |
Why?
| | Incidence | 2 | 2025 | 2915 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2011 | 780 | 0.060 |
Why?
| | Arthritis, Rheumatoid | 1 | 2015 | 1177 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2019 | 1332 | 0.060 |
Why?
| | Gestational Age | 2 | 2019 | 988 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2006 | 67 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2594 | 0.060 |
Why?
| | Personality Assessment | 1 | 2005 | 79 | 0.060 |
Why?
| | Length of Stay | 2 | 2022 | 1348 | 0.060 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2007 | 539 | 0.060 |
Why?
| | Deglutition | 1 | 2025 | 73 | 0.060 |
Why?
| | Transcriptome | 2 | 2022 | 1038 | 0.060 |
Why?
| | Ectodermal Dysplasia | 1 | 2005 | 20 | 0.060 |
Why?
| | Norway | 1 | 2024 | 41 | 0.050 |
Why?
| | Connexin 43 | 1 | 2005 | 36 | 0.050 |
Why?
| | Australia | 1 | 2005 | 289 | 0.050 |
Why?
| | Social Isolation | 1 | 2005 | 73 | 0.050 |
Why?
| | Connexins | 1 | 2005 | 54 | 0.050 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 2379 | 0.050 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2024 | 17 | 0.050 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2024 | 48 | 0.050 |
Why?
| | Mastectomy | 1 | 2025 | 181 | 0.050 |
Why?
| | Propensity Score | 1 | 2026 | 376 | 0.050 |
Why?
| | Ureteroscopy | 1 | 2022 | 15 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2005 | 289 | 0.050 |
Why?
| | Intubation, Intratracheal | 1 | 2026 | 326 | 0.050 |
Why?
| | Mammaplasty | 1 | 2025 | 141 | 0.050 |
Why?
| | Sample Size | 1 | 2022 | 122 | 0.050 |
Why?
| | Pruritus | 1 | 2022 | 59 | 0.050 |
Why?
| | Social Behavior | 2 | 2019 | 288 | 0.050 |
Why?
| | Paralysis | 1 | 2022 | 69 | 0.050 |
Why?
| | Lumbar Vertebrae | 1 | 2024 | 252 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2025 | 590 | 0.040 |
Why?
| | Upper Extremity | 1 | 2022 | 113 | 0.040 |
Why?
| | Hand | 1 | 2022 | 161 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2026 | 1044 | 0.040 |
Why?
| | Gene Expression | 1 | 2006 | 1478 | 0.040 |
Why?
| | Infant | 3 | 2020 | 10064 | 0.040 |
Why?
| | Tibia | 1 | 2022 | 176 | 0.040 |
Why?
| | Brain | 3 | 2023 | 2944 | 0.040 |
Why?
| | Students, Medical | 1 | 2025 | 375 | 0.040 |
Why?
| | Animals | 6 | 2019 | 38141 | 0.040 |
Why?
| | Bone Density | 1 | 2024 | 484 | 0.040 |
Why?
| | Mutation | 1 | 2011 | 4093 | 0.040 |
Why?
| | Social Sciences | 1 | 2019 | 8 | 0.040 |
Why?
| | Body Weight | 1 | 2024 | 970 | 0.040 |
Why?
| | Nebraska | 1 | 2019 | 21 | 0.040 |
Why?
| | Arkansas | 1 | 2019 | 23 | 0.040 |
Why?
| | Iowa | 1 | 2019 | 31 | 0.040 |
Why?
| | Receptors, Thrombopoietin | 1 | 2019 | 6 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2011 | 2185 | 0.040 |
Why?
| | Maryland | 1 | 2019 | 67 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1896 | 0.040 |
Why?
| | Wisconsin | 1 | 2019 | 99 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 31 | 0.040 |
Why?
| | New York | 1 | 2019 | 127 | 0.040 |
Why?
| | Ophthalmoscopy | 1 | 2018 | 38 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2019 | 85 | 0.040 |
Why?
| | Infrared Rays | 1 | 2018 | 26 | 0.040 |
Why?
| | Macaca fascicularis | 1 | 2018 | 70 | 0.040 |
Why?
| | Biometry | 1 | 2018 | 66 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2019 | 53 | 0.030 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2018 | 63 | 0.030 |
Why?
| | Morbidity | 1 | 2019 | 322 | 0.030 |
Why?
| | Age of Onset | 1 | 2020 | 554 | 0.030 |
Why?
| | Laryngeal Muscles | 1 | 2018 | 10 | 0.030 |
Why?
| | Voice Quality | 1 | 2018 | 24 | 0.030 |
Why?
| | Cefotaxime | 1 | 2017 | 3 | 0.030 |
Why?
| | Counseling | 1 | 2021 | 405 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 303 | 0.030 |
Why?
| | Age Distribution | 1 | 2018 | 403 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1677 | 0.030 |
Why?
| | Sex Distribution | 1 | 2018 | 387 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2018 | 147 | 0.030 |
Why?
| | Hospitals | 1 | 2022 | 732 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2024 | 631 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2018 | 529 | 0.030 |
Why?
| | Acute Disease | 1 | 2020 | 1040 | 0.030 |
Why?
| | Contactins | 1 | 2016 | 2 | 0.030 |
Why?
| | Peer Group | 1 | 2019 | 258 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 839 | 0.030 |
Why?
| | Odds Ratio | 1 | 2019 | 1082 | 0.030 |
Why?
| | Saccades | 1 | 2016 | 46 | 0.030 |
Why?
| | Linear Models | 2 | 2012 | 848 | 0.030 |
Why?
| | Reaction Time | 1 | 2018 | 438 | 0.030 |
Why?
| | Mice | 3 | 2019 | 18338 | 0.030 |
Why?
| | Mothers | 1 | 2022 | 767 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 497 | 0.030 |
Why?
| | Alcohol Abstinence | 1 | 2015 | 13 | 0.030 |
Why?
| | Cell Survival | 1 | 2019 | 1094 | 0.030 |
Why?
| | Survival Analysis | 1 | 2019 | 1374 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 5891 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 382 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1451 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2016 | 198 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1544 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2015 | 290 | 0.030 |
Why?
| | Finland | 1 | 2014 | 78 | 0.030 |
Why?
| | Logistic Models | 1 | 2019 | 2130 | 0.030 |
Why?
| | Rare Diseases | 1 | 2015 | 116 | 0.030 |
Why?
| | Genetic Phenomena | 1 | 2013 | 6 | 0.030 |
Why?
| | Synapses | 1 | 2017 | 438 | 0.030 |
Why?
| | Electroencephalography | 1 | 2016 | 563 | 0.020 |
Why?
| | Genetic Heterogeneity | 1 | 2013 | 65 | 0.020 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 64 | 0.020 |
Why?
| | Sex Factors | 1 | 2019 | 2110 | 0.020 |
Why?
| | Conduct Disorder | 1 | 2015 | 158 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2015 | 372 | 0.020 |
Why?
| | Risk-Taking | 1 | 2015 | 325 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 104 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3125 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3340 | 0.020 |
Why?
| | Parathyroidectomy | 1 | 2011 | 9 | 0.020 |
Why?
| | Chromatin | 1 | 2015 | 555 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 4127 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1815 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 44 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3537 | 0.020 |
Why?
| | Thyroidectomy | 1 | 2011 | 91 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4323 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3759 | 0.020 |
Why?
| | Pediatrics | 1 | 2018 | 1121 | 0.020 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 84 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4572 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2021 | 1953 | 0.020 |
Why?
| | Crohn Disease | 1 | 2013 | 259 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4283 | 0.020 |
Why?
| | Central Nervous System | 1 | 2012 | 282 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2022 | 2962 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 7171 | 0.020 |
Why?
| | Trachea | 1 | 2011 | 258 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4103 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2013 | 1139 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2014 | 1058 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4559 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2015 | 2045 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2011 | 644 | 0.020 |
Why?
| | Connexin 26 | 1 | 2005 | 9 | 0.010 |
Why?
| | Least-Squares Analysis | 1 | 2005 | 74 | 0.010 |
Why?
| | False Positive Reactions | 1 | 2005 | 123 | 0.010 |
Why?
| | Data Collection | 1 | 2008 | 639 | 0.010 |
Why?
| | Motor Cortex | 1 | 2005 | 66 | 0.010 |
Why?
| | Functional Laterality | 1 | 2005 | 242 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2005 | 409 | 0.010 |
Why?
| | Interviews as Topic | 1 | 2008 | 909 | 0.010 |
Why?
| | Psychomotor Performance | 1 | 2005 | 328 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1049 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 5202 | 0.010 |
Why?
| | Pain | 1 | 2005 | 787 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2005 | 3897 | 0.010 |
Why?
|
|
Keller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|